Free Trial

Cooper Companies (COO) Competitors

Cooper Companies logo
$78.83 -0.47 (-0.59%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$78.82 -0.01 (-0.01%)
As of 05/23/2025 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

COO vs. WST, ALGN, MMSI, HAE, ICUI, XRAY, QDEL, NEOG, STAA, and CERS

Should you be buying Cooper Companies stock or one of its competitors? The main competitors of Cooper Companies include West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), and Cerus (CERS). These companies are all part of the "health care supplies" industry.

Cooper Companies vs.

West Pharmaceutical Services (NYSE:WST) and Cooper Companies (NASDAQ:COO) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, community ranking, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends.

West Pharmaceutical Services has a net margin of 17.03% compared to Cooper Companies' net margin of 10.07%. West Pharmaceutical Services' return on equity of 18.60% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
West Pharmaceutical Services17.03% 18.60% 13.80%
Cooper Companies 10.07%9.38%6.09%

West Pharmaceutical Services currently has a consensus price target of $332.50, suggesting a potential upside of 61.67%. Cooper Companies has a consensus price target of $110.25, suggesting a potential upside of 39.86%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, analysts plainly believe West Pharmaceutical Services is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
West Pharmaceutical Services
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.00
Cooper Companies
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70

West Pharmaceutical Services has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500. Comparatively, Cooper Companies has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500.

In the previous week, West Pharmaceutical Services had 7 more articles in the media than Cooper Companies. MarketBeat recorded 43 mentions for West Pharmaceutical Services and 36 mentions for Cooper Companies. Cooper Companies' average media sentiment score of 0.98 beat West Pharmaceutical Services' score of 0.40 indicating that Cooper Companies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
West Pharmaceutical Services
12 Very Positive mention(s)
3 Positive mention(s)
23 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
Cooper Companies
22 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
3 Very Negative mention(s)
Positive

93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 0.5% of West Pharmaceutical Services shares are held by company insiders. Comparatively, 2.0% of Cooper Companies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Cooper Companies received 354 more outperform votes than West Pharmaceutical Services when rated by MarketBeat users. Likewise, 66.38% of users gave Cooper Companies an outperform vote while only 56.20% of users gave West Pharmaceutical Services an outperform vote.

CompanyUnderperformOutperform
West Pharmaceutical ServicesOutperform Votes
272
56.20%
Underperform Votes
212
43.80%
Cooper CompaniesOutperform Votes
626
66.38%
Underperform Votes
317
33.62%

West Pharmaceutical Services has higher earnings, but lower revenue than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
West Pharmaceutical Services$2.90B5.10$492.70M$6.3732.29
Cooper Companies$3.93B4.01$392.30M$2.0638.27

Summary

West Pharmaceutical Services beats Cooper Companies on 12 of the 19 factors compared between the two stocks.

Get Cooper Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COO vs. The Competition

MetricCooper CompaniesOphthalmic goods IndustryMedical SectorNASDAQ Exchange
Market Cap$15.76B$10.52B$5.34B$8.31B
Dividend YieldN/A0.96%5.27%4.11%
P/E Ratio40.4333.9326.9819.60
Price / Sales4.013.11398.81135.59
Price / Cash15.8714.5338.3234.64
Price / Book1.952.576.774.50
Net Income$392.30M$224.27M$3.24B$248.60M
7 Day Performance-4.93%0.81%0.27%-0.89%
1 Month Performance-2.55%10.83%5.90%7.41%
1 Year Performance-16.92%-24.09%18.83%8.56%

Cooper Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COO
Cooper Companies
3.1178 of 5 stars
$78.83
-0.6%
$110.25
+39.9%
-16.9%$15.76B$3.93B40.4314,000Trending News
Upcoming Earnings
Analyst Upgrade
WST
West Pharmaceutical Services
4.5454 of 5 stars
$217.00
+0.2%
$332.50
+53.2%
-38.0%$15.59B$2.90B32.4410,700Trending News
Analyst Forecast
ALGN
Align Technology
4.8104 of 5 stars
$184.84
-1.8%
$241.25
+30.5%
-33.2%$13.40B$3.98B32.9523,200News Coverage
Positive News
Gap Down
MMSI
Merit Medical Systems
4.1252 of 5 stars
$98.10
-0.7%
$108.67
+10.8%
+16.4%$5.80B$1.39B48.096,850News Coverage
Analyst Forecast
HAE
Haemonetics
4.3005 of 5 stars
$69.39
-1.3%
$97.89
+41.1%
-25.2%$3.49B$1.36B27.322,820Positive News
Analyst Forecast
ICUI
ICU Medical
4.7588 of 5 stars
$138.00
-2.4%
$192.67
+39.6%
+26.9%$3.40B$2.42B-30.2014,500Insider Trade
XRAY
DENTSPLY SIRONA
4.9792 of 5 stars
$16.63
-0.4%
$20.36
+22.5%
-43.7%$3.31B$3.72B-8.0315,000Positive News
Gap Down
QDEL
QuidelOrtho
4.4782 of 5 stars
$32.57
-2.7%
$44.33
+36.1%
-29.9%$2.20B$2.76B-1.087,000Positive News
NEOG
Neogen
3.2719 of 5 stars
$6.40
-3.2%
$9.00
+40.6%
-54.3%$1.39B$906.00M-2.922,110Positive News
Gap Down
STAA
STAAR Surgical
3.9559 of 5 stars
$19.25
+0.2%
$24.63
+27.9%
-54.6%$953.38M$279.13M-46.95960Positive News
Analyst Forecast
Buyback Announcement
CERS
Cerus
2.8364 of 5 stars
$1.32
-0.8%
$3.50
+165.2%
-32.1%$252.33M$185.14M-12.00290Positive News
Gap Down

Related Companies and Tools


This page (NASDAQ:COO) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners